Live
- RG Kar protest: Junior doctors to render medical services, carry out hunger strike in parallel
- Traffic Violators Counseled by Nagarkurnool Police
- Bathukamma Celebrations at Government Boys Junior College
- I Will Stand by the Mudiraj Community - MLA Dr. Rajesh Reddy
- Mission Bhagiratha DEE Hemalatha Distributes Certificates to Water Assistants in Achampet
- Elderly Man Dies Suddenly at Bus Stand
- DMK MP Wilson's conduct a threat to judicial impartiality and independence: BJP
- Lightning strikes claim nearly 300 lives in Bangladesh
- Haryana polls: Sohna records highest voting at 68.6 pc, Gurgaon registers lowest turnout
- Multiple attacks in Syria result in casualties
T-Hub signs MoU with pharmaceutical major Novartis Healthcare
T-Hub, a startup incubator set up by the Telangana Government today said it has signed an MoU with pharmaceutical major Novartis Healthcare Private Ltd (NHPL) to create and execute joint programs that would benefit HealthTech startups from across segments.
Hyderabad: T-Hub, a startup incubator set up by the Telangana Government today said it has signed an MoU with pharmaceutical major Novartis Healthcare Private Ltd (NHPL) to create and execute joint programs that would benefit HealthTech startups from across segments.
Being leaders in healthcare, Novartis will be working together with T-Hub to develop plans and programs that will help health tech, health care and pharmaceutical startups to scale and grow, according to a press release issued by the incubator.
As a part of the initiatives health, research and development experts from Novartis will mentor and guide startups, in compliance with T-Hubs mentorship framework and evaluation process, in their respective ventures, it said.
"We are very excited to collaborate with Novartis. It will bring great value to the ecosystem and HealthTech startups will be greatly benefited. With HealthTech being one of our prime sectors, we are working towards ensuring that startups associated with T-Hub are well mentored and guided through various programs of ours, which will help them scale their business faster," Jay Krishnan, CEO, T-Hub said.
Subodh Deshmukh, Global Drug Development India Head, Novartis said, "As a global leader in biomedical innovation, we are excited about this potential partnership with T-Hub and its allied startups driving innovation in the healthcare space."
